Guest guest Posted May 6, 2004 Report Share Posted May 6, 2004 http://www.medscape.com/viewarticle/475060 Selenium Levels Inversely Linked to Risk of Advanced Prostate Cancer By J. Brown, MD NEW YORK (Reuters Health) May 04 - High plasma levels of selenium are associated with a decreased risk of advanced prostate cancer, according to a report published in the May 5th issue of the Journal of the National Cancer Institute. This suggests that high levels of selenium may slow disease progression. The current study is one of several prospective epidemiologic studies to look at the link between selenium levels and prostate cancer. " Our study is the largest in terms of the sample size and the follow-up period, " lead author Dr. Haojie Li, from Harvard Medical School in Boston, told Reuters Health. " Also, we included patients diagnosed in both the pre- and post-PSA periods. " The researchers analyzed data from men enrolled in the Physicians' Health Study. Baseline selenium levels obtained in 1982 from 586 men diagnosed with prostate cancer during 13 years of follow-up were compared with levels from 577 control subjects. Men in the highest selenium level quintile were 48% less likely to develop advanced prostate cancer than men in lowest quintile (p = 0.05). Moreover, this inverse relationship was observed for men diagnosed before (pre-PSA era) or after (post-PSA era) October 1990. " There was a significant inverse association between selenium levels and overall prostate cancer risk, " Dr. Li said. " However, on further analysis, only the association with advanced cancer, not localized disease, was significant. " " A randomized trial, known as the Selenium and Vitamin E Cancer Prevention Trial (SELECT), is underway " that should definitively answer whether selenium use is beneficial in preventing prostate cancer, Dr. Li noted. J Natl Cancer Inst 2004;96:696-703. Reuters Health Information 2004. © 2004 Reuters Ltd. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.